The stock of TNF Pharmaceuticals Inc (TNFA) has gone up by 15.96% for the week, with a -49.57% drop in the past month and a -51.99% drop in the past quarter. The volatility ratio for the week is 19.17%, and the volatility levels for the past 30 days are 15.69% for TNFA. The simple moving average for the last 20 days is -26.26% for TNFA stock, with a simple moving average of -62.59% for the last 200 days.
Is It Worth Investing in TNF Pharmaceuticals Inc (NASDAQ: TNFA) Right Now?
The 36-month beta value for TNFA is also noteworthy at 2.26. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for TNFA is 2.62M, and at present, short sellers hold a 14.21% of that float. The average trading volume of TNFA on February 18, 2025 was 389.52K shares.
TNFA) stock’s latest price update
TNF Pharmaceuticals Inc (NASDAQ: TNFA)’s stock price has increased by 5.21 compared to its previous closing price of 0.57. However, the company has seen a 15.96% increase in its stock price over the last five trading sessions. businesswire.com reported 2025-01-29 that BALTIMORE–(BUSINESS WIRE)—- $TNFA–TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that it has initiated the first in a series of studies to evaluate the impact of its novel oral TNF-alpha (TNF-α) inhibitor drug, isomyosamine, in preserving lean muscle mass during and after GLP-1 treatment for weight loss and chronic weight management. “The b.
TNFA Trading at -44.63% from the 50-Day Moving Average
After a stumble in the market that brought TNFA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.38% of loss for the given period.
Volatility was left at 15.69%, however, over the last 30 days, the volatility rate increased by 19.17%, as shares sank -46.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -45.20% lower at present.
During the last 5 trading sessions, TNFA rose by +20.12%, which changed the moving average for the period of 200-days by -79.82% in comparison to the 20-day moving average, which settled at $0.8149. In addition, TNF Pharmaceuticals Inc saw -47.82% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TNFA
The total capital return value is set at -0.76. Equity return is now at value -142.68, with -103.16 for asset returns.
Based on TNF Pharmaceuticals Inc (TNFA), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -554.82.
Currently, EBITDA for the company is -4.0 million with net debt to EBITDA at 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.72.
Conclusion
In summary, TNF Pharmaceuticals Inc (TNFA) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
